SCHEMBL6971212

SCHEMBL6971212

O=C(O)OC1(c2ccc(Cl)cc2)OCC2(CO1)c1ccccc1-c1ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.37
HTT P42858 3/20 0.37
LMNA P02545 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
MDM2 Q00987 6/20 0.36
HSD11B1 P28845 2/20 0.35
CYP2D6 P10635 1/20 0.35
MEN1 O00255 1/20 0.34
XBP1 P17861 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
PGR P06401 2/20 0.34
TP53 P04637 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
SLC6A2 P23975 1/20 0.33
EDNRB P24530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981407 0.87 CNR1 (0.37) HSD11B1SIGMAR1
SCHEMBL6976227 0.85 ALDH1A1 (0.35) LMNAHSD11B1SLC6A2SLC6A4SLC6A3
SCHEMBL6975621 0.83 APP (0.38) CYP1A2CYP2C19HIF1ASMN1; SMN2LMNA
SCHEMBL6971210 0.80 CYP1A2 (0.41) CYP1A2CYP2C19HIF1ASMN1; SMN2HTT
SCHEMBL6978137 0.73 OPRM1 (0.43) SMN1; SMN2HTTLMNANPSR1MDM2
SCHEMBL6980629 0.72 APP (0.41) CYP1A2CYP2C19LMNAMEN1KMT2A
SCHEMBL7145811 0.70 APP (0.38) SMN1; SMN2HTTLMNAMEN1KMT2A
SCHEMBL6982681 0.69 THRB (0.44) NPSR1MEN1KMT2ATHRBTDP1
SCHEMBL6983604 0.68 OPRM1 (0.41) CYP1A2SMN1; SMN2LMNANPSR1MEN1
SCHEMBL6982483 0.68 KIF11 (0.44) CYP1A2CYP2C19HIF1ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP claimed